Zura Bio Ltd 8-K

What Happened

• Zura Bio Limited announced its full fiscal year 2025 financial results in a press release issued and furnished on March 19, 2026 (filed as Exhibit 99.1). The company also provided an updated corporate presentation on the same date (filed as Exhibit 99.2) that may be used in upcoming conferences and investor meetings. These disclosures were reported under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure) of Form 8-K.

Key Details

• Filing date: March 19, 2026 (Form 8-K).
• Press release announcing FY2025 results: Exhibit 99.1.
• Updated corporate presentation for investor use: Exhibit 99.2; also available at investors.zurabio.com (News & Events).
• Exhibits listed also include an Inline XBRL cover page (Exhibit 104).

Why It Matters

• This 8-K is the company’s official public release of its FY2025 financial results and an updated investor presentation — core materials investors use to assess recent performance, cash position, and outlook.
• The updated presentation under Regulation FD indicates the slides may be used broadly in investor communications; investors should review both the press release (Exhibit 99.1) and the presentation (Exhibit 99.2) for the specific revenue, expense, cash and guidance details that could affect valuation or investment decisions.
• For full numeric detail and context, retail investors should read the furnished exhibits and await any subsequent filings (e.g., Form 10-K or earnings call materials) for expanded financial statements and management commentary.